SHIFT Newsroom · GLOBAL
Semaglutide dose and mental-health outcomes: observational associations
An observational study in npj Metabolic Health and Disease found associations between higher attained semaglutide doses and fewer subsequent diagnoses in several neuropsychiatric categories.
An observational study in npj Metabolic Health and Disease found associations between higher attained semaglutide doses and fewer subsequent diagnoses in several neuropsychiatric categories. Participants were not randomly assigned to higher or lower doses for this comparison. Differences in health, treatment tolerance and other factors can affect the results. The findings do not prove that increasing a dose improves mental health and should not be used to alter a prescription.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.